logo

Biotech Daily Dose

Share

stockmarkets dec27 21jan21 What's moving these stocks in pre-market hours today?

biotech kan21 Today's Daily Dose brings you news about BNT162b2 vaccine's capability to neutralize the new UK coronavirus variant, the resignation of Stephen Hahn, the 24th Commissioner of the FDA, the executive changes at Lineage Cell Therapeutics and registered offering of OncoCyte.

stockmarkets dec21 20jan21 What's moving these stocks in pre-market hours today?

biotech jan20 Today's Daily Dose brings you news about another Alzheimer's disease drug failure, encouraging data of Aclaris' rheumatoid arthritis trial; Royalty Pharma/Minerva deal; Gritstone joining the COVID-19 vaccine race; and FDA imposing a clinical hold on Histogen's planned trial of HST-003 for knee cartilage regeneration.

stockmarkets aug20 19jan21 What's moving these stocks in pre-market hours today?

stockmarkets dec12 15jan21 What's moving these stocks in pre-market hours today?

biotech jan15 Today's Daily Dose brings you news about Lexicon's regulatory update on Sotagliflozin in heart failure; FDA approval of Pfizer's XALKORI in a new indication; Bicycle's pipeline progress update and Organogenesis' progress in knee osteoarthritis trial.

stockmarkets aug16 14jan21 What's moving these stocks in pre-market hours today?

pharma 010919 14jan21 Today's Daily Dose brings you news about Acorda's restructuring; Alexion's decision to pause its COVID-19 trial; and analyst's rating on Synlogic.

stockmarkets dec21 12jan21 What's moving these stocks in pre-market hours today?

biotech jan12 Today's Daily Dose brings you news about Lilly's Alzheimer's disease trial data, BeiGene's collaboration agreement with Novartis, Mesoblast's encouraging results from phase III trial of Rexlemestrocel-L in patients with chronic heart failure, and the resignation of Editas' Chief Scientific Officer.

stockmarkets dec27 11jan21 What's moving these stocks in pre-market hours today?

stockmarkets jan02 08jan21 What's moving these stocks in pre-market hours today?

biotech jan09 Today's Daily Dose brings you news about Alnylam's transthyretin-mediated (ATTR) amyloidosis trial results; Sarepta's mixed results of investigational gene therapy SRP-9001 in patients with Duchenne muscular dystrophy; Aldeyra's dry eye disease trial results; and Revance's anticipated milestones.

stockmarkets dec20 07jan21 What's moving these stocks in pre-market hours today?

Follow RTT